Therefore, we selected N-methyl-N-nitrosourea (MNU), an alkylating agent widely accepted for inducing gastrointestinal tumorigenesis40, to test whether Brca2 deficiency can elicit gastrointestinal tumor formation when increasing genome instability (Fig. 1d). This evidence concerns the gene BRCA2 and digestive system neoplasm.